M. J. Biopharm Private Limited Meropenem Export Data — India (DGFT 2022–2026)

Name: M. J. Biopharm Private Limited Meropenem Export Records India — #11 Exporter, 45 Shipments, $1.4M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Meropenem

India Pharmaceutical Trade Intelligence

$222.9M401 Suppliers134 CountriesHS 30049099

ExportsIndia → BELGIUM32.0%India → UNITED STATES15.5%

ImportsSWITZERLAND → India$418.3M BELGIUM → India$257.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

M. J. Biopharm Private Limited — Meropenem Exporter #11 | $2.1M Trade Value | TransData Nexus | TransData Nexus

M. J. Biopharm Private Limited — Meropenem Exporter Profile

Indian Pharmaceutical Exporter · #11 for Meropenem · $2.1M export value · DGFT Verified

M. J. Biopharm Private Limited is the #11 Indian exporter of Meropenem with $2.1M in export value and 45 verified shipments. M. J. Biopharm Private Limited holds a 0.6% market share in Meropenem exports across 9 countries. The company exports 6 pharmaceutical products worth $22.4M across 4 therapeutic categories.

M. J. Biopharm Private Limited — Meropenem Export Profile: Buyers & Destinations

M. J. Biopharm Private Limited Meropenem export treemap — buyers and destination countries | TransData Nexus

Where Does M. J. Biopharm Private Limited Export Meropenem?

Country	Value	Shipments	Share
NEPAL	$309.3K	15	27.6%
MYANMAR	$271.0K	9	24.2%
NIGERIA	$170.4K	5	15.2%
DOMINICAN REPULIC	$133.9K	5	12.0%
SUDAN	$64.4K	2	5.7%

Who Are the Top Buyers of Meropenem from M. J. Biopharm Private Limited?

Buyer	Country	Value	Orders
ADVANCE MEDICINE DISTRIBUTORS (P).	NEPAL	$309.3K	15
UNIQUE BROTHERS CO.LTD	MYANMAR	$182.9K	5
SIDPHARMA	DOMINICAN REPULIC	$152.7K	5
UNIQUE BROTHERS CO,LTD,	MYANMAR	$88.1K	4
TO THE ORDER OF FIDELITY BANK PLC	NIGERIA	$74.3K	2
M/S. LAMICHEM TRADING CO.LTD	SUDAN	$64.4K	2
TO THE ORDER OF UNITY BANK PLC	NIGERIA	$54.1K	2
INTERPHARMAS S.A. DE C.V.	EL SALVADOR	$46.4K	1
TO THE ORDER OF CORONATION MERCHANT	NIGERIA	$42.0K	1
ALFA PHARMA CORPORATION	YEMEN, DEMOCRATIC	$21.4K	1

M. J. Biopharm Private Limited supplies Meropenem to 17 buyers globally. The largest buyer is ADVANCE MEDICINE DISTRIBUTORS (P). (NEPAL), followed by UNIQUE BROTHERS CO.LTD (MYANMAR) and SIDPHARMA (DOMINICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Meropenem Formulations Does M. J. Biopharm Private Limited Export?

Product Description / Formulation	Value	Shipments
MONAN 1 G (MEROPENEM FOR INJECTION USP 1	$260.6K	9
MONAN 0.5 G (MEROPENEM FOR INJECTION USP	$86.8K	4
MIPENEM -1000 (MEROPENEM FOR INJECTION U	$84.1K	2
MONAN 1 G. (MEROPENEM FOR INJECTION USP	$75.0K	3
MONAN 1 G (MEROPENEM FOR INJECTION USP 1G) 40000 PACKS OF 1X1 GM	$70.6K	3
MONAN 1 G (MEROPENEM FOR INJECTION USP 1G) 38560 PACKS OF 1X1 GM	$50.0K	1
MIPENEM -1000 (MEROPENEM FOR INJECTION USP 1000 MG) 16667 PACKS OF 3X1000 MG	$50.0K	1
MONAN 1 G (MEROPENEM FOR INJECTIONUSP 1 G) 9384 PACKS OF 1X1GM	$50.0K	1
MONAN 1G (MEROPENEM FOR INJECTION USP 1G) 40000 PACKS OF 1X1 GM	$50.0K	1
MONAN 500 (MEROPENEM FOR INJECTIONUSP 500 MG) 60000 PACKS OF 1X500 MG	$46.4K	1

M. J. Biopharm Private Limited exports 29 distinct Meropenem formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MONAN 1 G (MEROPENEM FOR INJECTION USP 1 with 9 shipments worth $260.6K.

How Does M. J. Biopharm Private Limited Compare to Nearest Meropenem Exporters?

Exporters ranked immediately above and below #11 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	VENUS REMEDIES LTD	$1.6M	33	10	$50.0K
9	GLAND PHARMA LIMITED	$1.6M	33	2	$50.0K
11	M. J. BIOPHARM PRIVATE LIMITED ★	$1.4M	45	9	$32.1K
7	VHB MEDI SCIENCES LIMITED	$800.0K	16	4	$50.0K
4	GUFIC BIOSCIENCES LIMITED	$750.0K	15	4	$50.0K

M. J. Biopharm Private Limited ranks #11 among 401 Indian Meropenem exporters. Average shipment value of $32.1K compared to the market average of $200.8K. The closest competitors by value are VENUS REMEDIES LTD and GLAND PHARMA LIMITED.

Which Indian Ports Ship Meropenem Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	504	13.8%
DELHI AIR	494	13.5%
SAHAR AIR	256	7.0%
SAHAR AIR CARGO ACC (INBOM4)	246	6.7%
NHAVA SHEVA SEA (INNSA1)	233	6.4%
CMA CGM LOGISTICS PARK ICD (INCPL6)	198	5.4%
Delhi Air	103	2.8%
DHANNAD ICD (INDHA6)	94	2.6%

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Meropenem Exports

The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like M. J. Biopharm. Escalating tensions in the Middle East, particularly the Israel-Iran conflict, have disrupted key shipping routes through the Red Sea and the Suez Canal. Major carriers have suspended or rerouted shipments, leading to increased transit times and freight costs. This situation poses significant logistical hurdles for time-sensitive pharmaceutical exports. (livemint.com)

Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the U.S. has also implemented policies favoring domestic manufacturing, such as the "Buy American" initiative, which could impact Indian companies' access to this lucrative market. (walterhealthcare.co.in)

In the European Union, stringent regulations like the Falsified Medicines Directive necessitate rigorous compliance from exporters. Indian companies must navigate these complex requirements to maintain market access, emphasizing the need for robust quality assurance systems. (ipa-india.org)

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent guidelines to ensure product safety and efficacy. Indian companies have faced challenges, including increased compliance costs and potential reductions in export volumes due to evolving regulations. (transdatanexus.com)

For M. J. Biopharm, maintaining adherence to these standards is crucial to sustain and expand its export markets. Investments in quality control, staff training, and infrastructure are essential to meet the evolving requirements and to build trust with international partners and regulatory bodies.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Meropenem shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: M. J. Biopharm Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 45 individual customs records matching M. J. Biopharm Private Limited exporting Meropenem, covering 29 formulations to 10 countries via 17 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 134+ countries, 966+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Meropenem

Meropenem

M. J. Biopharm Private Limited — Meropenem Exporter Profile

M. J. Biopharm Private Limited — Meropenem Export Profile: Buyers & Destinations

Where Does M. J. Biopharm Private Limited Export Meropenem?

Who Are the Top Buyers of Meropenem from M. J. Biopharm Private Limited?

What Is India's Total Meropenem Export Value and How Much Does M. J. Biopharm Private Limited Contribute?

What Is the Average Shipment Value for M. J. Biopharm Private Limited's Meropenem Exports?

How Does M. J. Biopharm Private Limited Compare to Other Indian Meropenem Exporters?

What Meropenem Formulations Does M. J. Biopharm Private Limited Export?

Regulatory Requirements: Exporting Meropenem to Key Markets

Nigeria — NAFDAC

How Does M. J. Biopharm Private Limited Compare to Nearest Meropenem Exporters?

Which Indian Ports Ship Meropenem Exports?

What Other Advanced Antibiotics Products Does M. J. Biopharm Private Limited Export?

Geopolitical & Trade Policy Impact on M. J. Biopharm Private Limited's Meropenem Exports

M. J. Biopharm Private Limited — Regulatory Compliance & Quality Standards

About M. J. Biopharm Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Meropenem Export Data from M. J. Biopharm Private Limited

Meropenem Stats

Company Overview

Top Products by M. J. Biopharm Private Limited

Related Analysis

Need Detailed Export Data?

Data Source